Corporate Profile

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Gilead has operations in more than 30 countries worldwide, with headquarters in Foster City, California.

Recent Press Releases

February 02, 2016 - 4:02 p.m.
Gilead Sciences Announces Declaration of Q1 Cash Dividend and Increases to Shareholder Return ProgramsPrinter Friendly Version 
February 02, 2016 - 4:01 p.m.
Gilead Sciences Announces Fourth Quarter and Full Year 2015 Financial ResultsPrinter Friendly Version 

Upcoming Events

Tuesday, February 9, 2016
18th Annual BIO CEO & Investor Conference
LocationNew York, NY
Wednesday, February 10, 2016
Leerink Partners 5th Annual Global Healthcare Conference
LocationNew York, NY
Saturday, February 20, 2016 through Wednesday, February 24, 2016
Asian Pacific Association for the Study of the Liver (APASL)
LocationTokyo, Japan
Monday, February 22, 2016 through Thursday, February 25, 2016
Conference on Retroviruses and Opportunistic Infections (CROI)
LocationBoston, MA
Wednesday, April 13, 2016 through Sunday, April 17, 2016
The International Liver Congress 2016: European Association for the Study of the Liver (EASL)
LocationBarcelona, Spain

Most Viewed Links

Updated 01/26/16
1.SEC Filings
3.Stock Information
4.Annual Reports
5.Fundamentals - Snapshot
* Data collected 01/18/16 - 01/25/16

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
NASDAQ (US Dollar)
 Stock is Down 1.54 (1.78%)
Data as of 02/05/16 4:00 p.m. ET
Minimum 20 minute delay
Refresh Quote
Recent Webcasts
Fourth Quarter 2015 Gilead Sciences Earnings

February 02, 2016 4:30 p.m. ET
J.P. Morgan 34th Annual Healthcare Conference

January 11, 2016 10:30 a.m. ET